药物输送系统市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPHE100000854
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 289
Buy Now

[研究报告]2018年给药系统市场价值为1,243,111.7百万美元,预计2027年将达到2,302,227.2百万美元;预计 2019 年至 2027 年复合年增长率为 7.2%。

分析师观点:

全球给药系统市场主要受到不断增长的推动糖尿病、心血管疾病和癌症等慢性病的流行,以及药物输送创新设备制造和开发的技术进步。糖尿病是肾衰竭、心脏病、失明和中风的主要原因。因此,全球各种慢性病患病率的迅速上升,极大地增加了对各种创新治疗药物的需求,从而促进了给药系统市场的增长。

生物制药行业的快速发展和生物制药行业的发展各种新的创新药物正在显着推动药物输送系统市场的增长。顶级制药商在治疗疑难杂症的新药研发方面的投资不断增加,这增加了全球对各种药物输送解决方案的需求。此外,药物输送系统市场的几家顶级市场参与者以及产品发布、并购等关键发展策略都在不断变化。他们采取的收购和合作伙伴关系极大地推动了市场的增长。因此,全球药物和基因递送设备公司的渗透率不断上升正在推动市场增长。

市场概述:

药物递送系统(DDS)是一种制剂或药物该装置能够将治疗物质引入体内,通过控制药物释放到体内的速率、时间和地点来提高其功效和安全性。药物输送系统在过去六十年中取得了长足的发展。在过去 12 年里,药物输送技术取得了巨大进步。例如,先进的药物输送系统,如透皮贴剂,能够更有选择性地将药物输送到特定部位,这通常会导致更容易、更准确和更少的总体剂量。还有其他用于医疗和家庭护理环境的药物输送系统,这些系统是根据不同的患者需求而开发的,研究人员不断开发新方法。

战略见解

市场驱动因素:

慢性病发病率上升推动药物输送系统市场增长

由于药物输送设备有助于输送药物,有利于目标人群更快地康复,因此出现了越来越多地采用和倾向于先进的药物输送设备。此外,全球癌症、呼吸道疾病和糖尿病患者数量的增加可能会促进药物输送系统的采用并推动整个市场。据世界卫生组织(WHO)称,癌症是全球最大的死亡原因,2020年约有1000万人死亡。总体而言,全球癌症发病率和死亡负担正在迅速增加。根据 CDC 的数据,2020 年,美国报告了 1,603,844 例新癌症病例,602,347 人死于癌症。乳腺癌、结直肠癌、肺癌、宫颈癌和甲状腺癌在女性中很常见。相比之下,肺癌和前列腺癌在男性中最常见,占所有男性癌症的近三分之一。癌症负担的不断增加增加了药物输送设备的采用,极大地促进了药物输送系统市场的增长。

细分分析:

根据应用,药物输送系统市场是分为家庭护理机构、医院和医疗机构。诊所和其他。 2018年,医院和诊所部门在给药系统市场中占据主要份额。预计在预测期内,家庭护理设置领域的给药系统市场将出现显着增长。医院是一个复杂的组织和机构,通过复杂但专业的科学设备和受过现代医学科学问题教育的训练有素的工作人员团队为人们提供健康。他们为了恢复和保持健康的共同目标而协调一致。医院通过为患有各种疾病的患者群体提供广泛的医疗服务而发挥着重要作用。这增加了医院和诊所对药物输送系统的采用。例如,根据美国疾病控制与预防中心 (CDC) 的数据,2014 年,美国 18 岁及以上成年人口中共有 720 万人因糖尿病出院。预计这将增加控制和治疗慢性病的治疗过程,进而有望增加医院中药物输送系统的使用。

区域分析:

在北美地区,美国是最大的给药系统市场。该市场的增长主要是由于糖尿病、哮喘等慢性疾病的患病率不断上升,主要参与者推出的产品数量不断增加;以及更多地使用药物输送装置进行疾病管理。据美国国家卫生统计中心预测,2023年,美国预计将新增190万癌症病例,609,820例癌症死亡,且该国癌症病例预计将进一步增加,这预计将增加对癌症的需求。由于癌症死亡率高,该地区对癌症治疗的需求相当高,因此用于各种治疗方法的药物输送系统预计将促进药物输送系统市场的增长。

此次推出该国的新产品也将有助于推动给药系统市场的增长。例如,2022 年 2 月,美国 FDA 批准了仿制药 Apokyn(盐酸阿扑吗啡注射液)药筒,用于治疗与晚期帕金森病相关的活动不足和其他发作。 2021 年 1 月,诺华公司投资了 Credence MedSystems,以支持其药物输送系统的开发和扩大规模。这一举措促进了诺华公司 (Novartis AG) 在其注射药物中使用 Credence 技术。同样,2020 年 11 月,Croda International PLC 与辉瑞公司达成协议,为辉瑞的 COVID-19 候选疫苗提供创新的药物输送系统。

此外,2022 年 3 月,Corium 获得美国 FDA 批准批准 Adlarity 用于治疗与阿尔茨海默病相关的轻度、中度或重度痴呆患者。在该国推出透皮贴剂预计将在研究期间提振所研究的市场。此外,市场参与者的战略举措,例如增加药物输送设备产量的伙伴关系和协作,将带来利润丰厚的市场增长。例如,2020 年 5 月,美国国防部和美国卫生与公众服务部向 ApiJect Systems America 授予了一份价值 1.38 亿美元的“Project Jumpstart”和“RAPID USA”合同,双方将共同扩大美国医疗级注射器械的生产能力。

主要参与者分析:

给药系统市场分析由BD、3M、Novo Nordisk A/等参与者组成S、BD、诺和诺德公司、3M、波士顿科学公司、博士健康公司、百特国际公司、勃林格殷格翰、诺华公司、葛兰素史克公司。和强生公司Johnson Services, Inc. 在药物输送系统市场的参与者中,3M 和 BD 由于提供多样化的产品组合而成为排名前两位的参与者。

最新动态:

药物输送系统市场的公司高度采用并购等无机和有机策略。下面列出了最近的一些关键市场发展:

  • 2022 年 6 月,Gufic Biosciences Ltd 首次在印度以实惠的价格推出了新型药物输送系统双室袋。 Gufic 的这些即用型双室袋最重要的 USP 之一是它们可以防止污染并保护药物的效力和功效。这些袋子在冲调时也易于处理,并且还有助于避免稀释错误,因为药物中含有所需使用的准确数量的稀释剂。
  • 2022 年 2 月,武田 (Takeda) 收到了美国 FDA 批准 TAKHZYRO (lanadelumab-flyo) 采用单剂量预充式注射器 (PFS) 注射,用于预防成人和 12 岁及以上儿童患者的遗传性血管水肿 (HAE) 发作。 PFS 可以立即使用,并且比当前的 TAKHZYRO 小瓶注射所需的准备步骤更少,同时还减少了供应和浪费。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

  1. BD (Becton Dickinson & Company)
  2. Boston Scientific Corporation
  3. Novo Nordisk A/S
  4. Bausch Health Companies Inc.
  5. Baxter International, Inc.
  6. Boehringer Ingelheim
  7. Novartis AG
  8. GlaxoSmithKline plc.
  9. Johnson & Johnson Services, Inc.
  10. Terumo Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports